Home / News / India News / Article /
SC to decide pharma patent, take up marines case
Updated On: 01 April, 2013 09:18 AM IST | | Agencies
The Supreme Court will pronounce an important judgment Monday on a Swiss pharma firm's plea asserting its patent over a medicine, and Tuesday take up Sterlite's plea opposing the order to shut down its plant as well as the case of the Italian marines.
In a judgment that would have a far-reaching implication for the Indian pharmaceutical industry, the court will rule on Novartis AG plea seeking a patent for the beta-crystalline form of imatinib mesylate, which is used in the treatment of chronic mycloid leukaemia.
International drug makers are critical of Section 3(d) of the Indian Patent Act which says that mere discovery of a new form of a known substance which does not result in the enhancement of the known efficacy of that substance does not qualify for patent protection.


